Lifotronic Technology Secures New Medical Device Registration Certificate

Stock News
03/03

Shenzhen Lifotronic Technology Co., Ltd. (688389.SH) has announced the recent receipt of a Medical Device Registration Certificate for In Vitro Diagnostic Reagents issued by the Guangdong Provincial Medical Products Administration. The newly registered product is an Erythropoietin (EPO) Assay Kit utilizing electrochemiluminescence technology. This kit employs a sandwich chemiluminescence immunoassay method with dual antibodies, offering high sensitivity and precision. The addition of this kit further enriches and completes the company's electrochemiluminescence reagent testing portfolio, which is expected to enhance its market competitiveness in the field of immunodiagnostics.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10